Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

dual tasking

- PMLiVE

AstraZeneca and Daiichi Sankyo’s Enhertu shows significant improvements for lung cancer patients

Data showed a confirmed objective response rate of 53.8% in patients with HER2-mutant metastatic non-small cell lung cancer

regeneron headquarters

Regeneron’s fianlimab/Libtayo combination shows positive results in advanced melanoma treatment

The results were shared at the European Society for Medical Oncology Congress 2022

Pharmacogenomics

Pharmacogenomics supports and new era of precision medicine

Advances in medical science are always working towards the same goals; to improve quality of life, and clinical and economic outcomes for patients, caregivers, and health providers alike. But drug...

Page & Page Health

- PMLiVE

Building a brighter future with patient support programmes

By Danny Buckland

- PMLiVE

The benefits of patient support programmes in specific disease areas

By Charlotte Maule

- PMLiVE

AstraZeneca shares positive Tagrisso data in patients with EGFR-mutated lung cancer

Lung cancer is the leading cause of cancer death among both men and women

- PMLiVE

Amgen announces positive results for Lumakras colorectal cancer combination treatment

Results demonstrated a confirmed objective response rate of 30% and median progression free survival of 5.7 months

regeneron headquarters

Regeneron’s Libtayo shows promising results in phase 2 skin cancer trial

In the phase 2 trial, 50.6% of patients achieved the primary endpoint of complete pathologic response

- PMLiVE

OPEN Health appoints Stephen Chick as chief growth officer for Evidence & Access

Chick joins the consultancy from his role as vice president of business development at Symphony Health

- PMLiVE

MedscapeLIVE! to Host “Neurology Exchange” Virtual Conference

Leading Neurology Faculty to Present Clinical Updates and Management Strategies for Key Neurological Conditions

Medscape Education

Biotech Innovation in the Time of COVID-19

Chris Garabedian, CEO of Xontogeny, dives into biotech and digital health innovation, current industry gaps and obstacles, how to encourage biotech entrepreneurs, AI & machine learning, and much more!

Impetus Digital

- PMLiVE

Breaking Internal Silos to Ensure Patient Centricity is a Key Focus Company-Wide

Mark and Urs will be discussing the pros and cons of an enterprise-wide approach to patient centricity, and explore the measurable benefits it could deliver. • Who should be involved...

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links